Tag: Pharmaceuticals
Mauna Kea Technologies: creation of a joint venture and licensing agreements with Tasly Pharmaceuticals
By Olivier Cheilan Published on 07/11/2022 at 6:05 p.m. Photo credit © Mauna Kea …
Mauna Kea: towards a joint venture with Tasly Pharmaceuticals – 07/11/2022 at 18:07
(CercleFinance.com) – Mauna Kea Technologies announces the signing of a strategic agreement with Tasly Pharmaceuticals to create a joint venture (JV). Under the terms of the agreement, this joint venture…
Mauna Kea: towards a joint venture with Tasly Pharmaceuticals
(CercleFinance.com) – Mauna Kea Technologies announces the signing of a strategic agreement with Tasly Pharmaceuticals to create a joint venture (JV). Under the terms of the agreement, this joint venture…
Mithra Pharmaceuticals SA: CDMO announces collaboration with MedinCell for the development of injectables against malaria and transplant rejection
Liège, Belgium, April 26, 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, announces today that it has signed a partnership agreement with MedinCell…
Mithra Pharmaceuticals SA: Extension of the duration of the capital commitment agreement with LDA capital for a period of two years and increase of EUR 25 million in the total amount of the commitment
Liège, Belgium, April 18, 2022 -07:30 CEST – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (“Mithra” or the “Company”), a company dedicated to women’s health, today announces the extension of the…
Zentalis Pharmaceuticals, Inc.: Wells Fargo Securities Raises Its Buy Recommendation
Marketzone with MT Newswires 2022 All the news about ZENTALIS PHARMACEUTICALS, INC. Analyst Recommendations for ZENTALIS PHARMACEUTICALS, INC. 2022…
Ionis Pharmaceuticals, Inc.: Piper Sandler still on the buy
Marketzone with MT Newswires 2022 All the news about IONIS PHARMACEUTICALS, INC. Analyst Recommendations for IONIS PHARMACEUTICALS, INC. 2022…
Avadel Pharmaceuticals plc: Craig-Hallum persists in buying
Marketzone with MT Newswires 2022 503 Backend fetch failed Backend fetch failed Meditation Guru: XID: 74645677 Varnish cache server 503 Backend fetch…
Virpax Pharmaceuticals extends its development and commercialization rights for AnQlar™ through a worldwide licensing agreement
– AnQlar™ has already demonstrated antiviral activity against influenza and SARS-CoV-2 in three preclinical studies – — The FDA has notified Virpax that the company is authorized to file an…
Ionis Pharmaceuticals, Inc.: Guggenheim is no longer for sale
Marketzone with MT Newswires 2022 All the news about IONIS PHARMACEUTICALS, INC. Analyst Recommendations for IONIS PHARMACEUTICALS, INC. 2022…
OSE Immunotherapeutics is pleased to announce FDA Fast Track Designation for CD28 antagonist VEL-101/FR104, granted by Veloxis Pharmaceuticals, Inc., its partner in transplantation – 02/17/2022 18:00
Nantes, France – February 17, 2022, 6:00 p.m. – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces that Veloxis Pharmaceuticals, Inc., a subsidiary of Asahi Kasei, has obtained “Fast Track”…
Mithra and Searchlight Pharmaceuticals announce the commercial launch of Haloette® in Canada – 02/16/2022 at 07:30
LIÈGE (Belgium – 7:30 AM CET) and MONTREAL (Canada – 7:00 AM EST), February 16, 2022 – Mithra and Searchlight Pharmaceuticals are pleased to announce the commercial launch of the…